Figure 8: Body weight loss and DAI of C57BL/6J mice with acute DSS-induced colitis treated with peptide inhibitors. | Nature Communications

Figure 8: Body weight loss and DAI of C57BL/6J mice with acute DSS-induced colitis treated with peptide inhibitors.

From: Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease

Figure 8

Representation of relative body weight loss, absolute body weight loss at time of killing and DAI for control and DSS-induced mice included in the therapeutic scheme (n=30) (a–c), the prophylactic scheme (n=24) (d–f) and for control and DSS-induced mice subcutaneously implanted with osmotic pumps yielding continuous delivery of sufficient amounts of peptide inhibitor (n=24) (g–i). Median values with interquartile range are represented when applicable. Statistical analyses were performed with Mann–Whitney U tests (*P<0.05).

Back to article page